43838-MAG-S-MINAE of December 14, 2022, and its reforms, so that they read as follows:
"ANNEX N (NORMATIVE) REQUIREMENTS FOR THE REGISTRATION OF ACTIVE INGREDIENT OF MINERAL OR INORGANIC ORIGIN A) ADMINISTRATIVE INFORMATION FILE 1. Submit the completed application form for Active Ingredient registration (Annex A), in each of its sections.
2. Proof of payment of the current fee.
3. Safety data sheet for the Active Ingredient, it must contain the internationally standardized requirements using as a model the guidelines of the "Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations." 4. Label: The label must be submitted only if the Active Ingredient will be imported into the country. The information on the label must match what is indicated in the dossier.
- B)CONFIDENTIAL INFORMATION FILE:
1. Certificate of Qualitative-Quantitative Composition of the active ingredient of mineral or inorganic origin, issued by the parent company or by the manufacturer and signed by the responsible professional. It must be submitted signed in original or a copy certified by a notary public, which will contain:
1.1 Minimum concentration of the mineral or inorganic active ingredient expressed in percentage m/m or g/Kg or percentage m/v or g/L (of the metal ion that possesses the biocidal action) according to the physical state of the product. In case the concentration is indicated in m/v, the density must be declared in g/cm3 or g/mL units.
1.2 Maximum concentration of each impurity greater than or equal to one gram per kilogram (1 g/kg) or 0.1% m/m.
1.3 Maximum concentration of relevant impurities, in case they are not present, the absence of the same must be indicated.
1.4 Minimum and maximum concentration of other additives present, expressed in g/kg, g/L, or percentage, when appropriate and applicable to the specific case. Must indicate the function (e.g., stabilizer).
1.5 The identity of the active ingredient, impurities, and additives (the latter when appropriate and applicable to the specific case) must be indicated according to their chemical name under IUPAC and the CAS number when available; if not available, the chemical structure must be presented.
2. Certificate of analysis of the active ingredient of mineral or inorganic origin and relevant impurities, issued less than two years prior by the parent company or by the manufacturer of the product, original or a copy certified by a notary public and signed by the responsible professional. It must include lot number, date of analysis, result obtained for the active ingredient(s) and relevant impurities. In the event that the certificate of analysis was issued by the parent company, the manufacturer must be indicated therein.
(Normative) REQUIREMENTS FOR THE REGISTRATION OF CHEMICAL PESTICIDES OF MINERAL OR INORGANIC ORIGIN A) ADMINISTRATIVE INFORMATION FILE 1. Submit the completed application form for registration of the chemical pesticide of mineral or inorganic origin (Annex D), in each of its sections.
2. Proof of payment of the current fee.
3. Safety data sheet for the chemical pesticide of mineral or inorganic origin, must contain the internationally standardized requirements using as a model the guidelines of the "Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations" 4. Label. The information on the label must coincide with what is indicated in the dossier.
5. Leaflet. The information in the leaflet must coincide with what is indicated in the dossier and with the approval resolution of the efficacy trial, issued by the Control Unit of the SFE.
- B)TECHNICAL INFORMATION FILE OF THE DOSSIER - CHEMICAL REQUIREMENTS 1. Analytical method(s) used for the determination of the active ingredient contained in the chemical pesticide of mineral or inorganic origin with its respective validation.
2. Studies on the determination of physical and chemical properties.
2.1 Appearance.
2.2 Color.
2.3 Odor.
2.4 Stability in storage, must indicate the packaging material.
2.5 Density (solids and liquids).
2.6 Flammability or flash point.
2.7 pH.
2.8 2.9 Corrosivity.
2.10 Viscosity (for liquid substances) 3. Studies on the determination of physical properties related to use. Submit the study when applicable.
3.1 Wettability. Applicability: all solid formulations to be dispersed or dissolved in water. Methodology: MT 53.3 Wettability of wettable powders or current or another internationally recognized method.
3.2 Persistent foaming. Applicability: All formulations intended for dilution with water before use. Methodology: MT 47.3 Persistent foaming or current or another internationally recognized method.
3.3 Particle size analysis in wet. Applicability: To wettable powders (WP), suspension concentrates including those intended for seed treatment and oil-based (SC, FS, and OD); water-dispersible granules (WG), aqueous capsule suspensions (CS), dispersible concentrates (DC), suspo-emulsions (SE), water-soluble tablets and dispersible tablets (ST and WT); and emulsifiable granules and powders (EG and EP). Methodology: MT 182 Wet sieving using recycled water; MT 185 Wet sieve test, the preferred method, a review of methods MT 59.3 and MT 167 or current or another internationally recognized method.
3.4 Particle size analysis in dry. Applicability: Powders and granules intended for direct application. Methodology: MT 170 Dry sieve analysis of water-dispersible granules (WG) or current or another internationally recognized method.
3.5 Dispersibility and spontaneity of dispersion. Applicability: To suspension concentrates (SC), aqueous capsule suspensions (CS), and water-dispersible granules (WG).
Methodology: MT 160 Spontaneity of dispersion of suspension concentrates; MT 174 Dispersibility of water-dispersible granules or another internationally recognized method.
3.6 Suspensibility. Applicability: Wettable powders (WP), suspension concentrates (SC), flowable concentrate for seed treatment (FS) that is diluted for use, capsule suspensions (CS), water dispersible granules (WG), and water dispersible tablets (WT). Methodology: MT 184 Suspensibility of formulations forming suspensions in water dilution (a harmonization of methods MT 15, MT 161, and MT 168) or the current version or another internationally recognized one.
3.7 Emulsion stability and re-emulsification. Applicability: To emulsifiable concentrates (EC), oil-in-water emulsions (EW), and micro-emulsions (ME). Methodology: MT 36.3 Emulsion characteristics of emulsifiable concentrates or the current version or another internationally recognized one.
3.8 Flowability. Applicability: Water dispersible granules (WG), water soluble granules (SG), granules (GR), and emulsifiable granules (EG). Methodology: MT 172.1 Flowability of granular preparations after accelerated storage under pressure or the current version or another internationally recognized one.
AGRONOMIC REQUIREMENTS Indicate the resolution number approving the product efficacy trial, issued by the SFE Inspection Unit, for each of the uses for which registration is requested or the representative crop of the corresponding group.
TOXICOLOGICAL REQUIREMENTS FOR EVALUATION BY THE MS The following complete studies must be submitted, including the cover page, introduction, materials, methods, results, references, and the consolidated data tables supporting the results. Appendices with the daily data logs, photos, figures, protocols, chromatograms, and statistical sheets are not necessary for the analysis.
1. Acute oral median lethal dose (LD50), expressed in mg/kg of body weight (OECD Technical Guideline number 423). This study will be required in all cases unless the product is a gas or is highly volatile.
2. Acute dermal median lethal dose (LD50), expressed in mg/kg of body weight (OECD Technical Guideline number 402). This study will be required unless:
2.1. The product is a gas or is highly volatile.
2.2. The product is corrosive to the skin or has a pH less than 2 or greater than 11.5.
3. Acute inhalation median lethal concentration (LC50), expressed in mg/L of air or mg/m3, for 4 hours of exposure (OECD Technical Guideline number 403). This will be requested when:
The product is a gas or liquefied gas, is a smoke-generating preparation or a fumigant, is used with fogging equipment, is a preparation that releases vapor, is an aerosol, is a powder containing a significant proportion of particles with a diameter less than 100 micrometers, is applied from an aircraft, contains active substances with a vapor pressure greater than 1 x 10-2 Pa and is to be used in enclosed spaces, or is to be applied in such a way that it generates particles or droplets with diameters less than 100 micrometers.
4. Dermal irritation (OECD Technical Guideline number 404). This study will be required unless:
4.1. The product is a gas or is highly volatile.
4.2. The product is corrosive to the skin or has a pH less than 2 or greater than 11.5.
5. Ocular irritation (OECD Technical Guideline number 405). This study will be required unless:
5.1. The product is a gas or is highly volatile.
5.2. The product is corrosive to the eyes or has a pH less than 2 or greater than 11.5.
6. Skin sensitization (OECD Technical Guideline number 406). This study will be required in all cases, except when:
The product is known to be a skin sensitizer.
7. Demonstrate that the requested use pattern of the chemical pesticide of mineral or inorganic origin is in compliance with the MRL adopted by the country for the requested crop, fulfilling what is indicated in numeral 8.2.2 of this regulation. Excepted from this numeral are chemical pesticides of mineral or inorganic origin that are exempt from an MRL.
8. Human health risk assessments conducted by the applicant will be accepted for analysis. In the case of the pesticide registration by homologation modality, the human health assessment conducted by the OECD and adherent country in which it is registered or authorized will be accepted.
ECOTOXICOLOGICAL REQUIREMENTS The following studies must be submitted, including the cover page, introduction, materials, methods, results, references, and the consolidated data tables supporting the results.
Appendices with the daily data logs, photos, figures, protocols, chromatograms, and statistical sheets are not necessary for the analysis and must not be provided.
Regarding the guidelines indicated in this section, they are the recommended ones and are cited for the applicant's clarity on the type of study required. However, the studies may have been conducted with any other recognized guideline that meets similar parameters, following what is indicated in numerals 8.1.7 or 8.1.8 of the decree.
1. Ecotoxicological studies 1.1. Acute oral toxicity in birds. Must comply with what is indicated in guideline OCSPP 850.2100 and OECD 223.
1.2. Acute oral toxicity study for bees. Must comply with what is indicated in guideline OECD 213.
1.3. Acute contact toxicity study for bees. Must comply with what is indicated in guidelines OECD 214 and OCSPP 850.3020.
1.4. Toxicity study for earthworms. Must comply with what is indicated in guidelines OCSPP 850.3100, OECD 222, or OECD 207.
1.5. Toxicity study for the soil microorganism community: nitrogen transformation. Must comply with what is indicated in guidelines OECD 216 and OCSPP 850.5100.
1.6. Toxicity study for the soil microorganism community: respiration. Must comply with what is indicated in guidelines OECD 217 and OCSPP 850.5100.
1.7. Acute toxicity in fish. Must comply with what is indicated in guideline OECD 203 or Guideline OCSPP 850.1075.
1.8. Bioaccumulation in fish. Must comply with what is indicated in guideline: OECD 305 or OCSPP 850.1730.
1.9. Acute toxicity in Daphnia sp. Must comply with what is indicated in guideline: OECD 202 or OCSPP 850.1010.
1.10. Effect on the growth of algae or aquatic plants. Must comply with what is indicated in guideline: OECD 201 or OCSPP 850.5400.
1. Certificate of the qualitative-quantitative composition of the chemical pesticide of mineral or inorganic origin, original or copy certified by a notary public, issued less than two years ago by the parent company or the formulator and signed by the responsible professional, and must contain:
1.1 Nominal content expressed as percentage m/m or m/v of active ingredient calculated from the minimum concentration declared in the registration of the active ingredient, as well as, if applicable, the corresponding content of variants (such as salts and esters) of the active substances.
1.2 Nominal content of each co-formulant in the formulation expressed as percentage m/m or m/v.
1.3 Function of each of the co-formulants included in the formulation.
1.4 The identity of the co-formulants and the active ingredient must be indicated according to their IUPAC chemical name and CAS number when available. If not available, the chemical structure must be attached. If codes are used to identify the co-formulants, the function must be described and the safety data sheet of the co-formulant must be provided, only if it lacks a CAS number or IUPAC name. When the co-formulants are mixtures, their composition must be indicated. In the event that it is a proprietary mixture protected under trade secret, the safety data sheet may be presented in its place.
1.5 Density of the formulation (must indicate the units and temperature) in units of g/cm3 or g/mL.
1.6 Maximum content of relevant impurities, when present.
2. Analysis of five lots (at minimum) typical of the formulated product to be registered, attaching the results of the corresponding analyses of the active ingredient for each analyzed lot of the chemical pesticide of mineral or inorganic origin formulated no more than 5 years ago. If applicable, attach the corresponding chromatograms of the active ingredient for each lot, their identification with the date of analysis and formulation, formulator, and the results obtained for each, with the areas of each chromatogram peak and data of the formula used to obtain the result, or sample calculation.
3. Description of the formulation process: The company must present information on the formulation processes of the chemical pesticide of mineral or inorganic origin subject to registration.
For each process, the following information must be provided:
3.1 Name and address of the formulator involved in the process.
3.2 General characterization of the process.
3.3 Indicate the ingredients used to formulate the product.
3.4 Description of the equipment used.
3.5 Description of the conditions controlled during the process.
(Normative) REQUIREMENTS FOR THE REGISTRATION OF TGAI WITH REFERENCE INFORMATION FROM AN INTERNATIONALLY RECOGNIZED AUTHORITY.
- A)ADMINISTRATIVE DOSSIER OF THE FILE 1. Submit the duly completed application form for registration of a Technical Grade Active Ingredient (Anexo A), in each of its sections.
2. Proof of payment of the current fee.
3. Safety data sheet with its respective chemical endorsement of the technical grade active ingredient; it must contain internationally standardized requirements using as a model the guidelines of the "Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations." 4. Label. The label must be submitted only if the TGAI is to be imported into the country. The information on the label must match what is indicated in the file.
- B)CONFIDENTIAL DOSSIER OF THE FILE 1. Certificate of quantitative qualitative composition of the technical grade active ingredient issued by the parent company or the manufacturer and signed by the responsible professional. It must be submitted signed in original or as a copy certified by a notary public, which will contain:
1.1. Minimum concentration of the technical grade active ingredient expressed as percentage m/m (or g/kg) or percentage m/v or g/L. If the concentration is indicated in m/v, the density must be declared in units g/cm3 or g/mL.
1.2. Maximum concentration of each impurity greater than or equal to one gram per kilogram (1 g/kg) or 0.1% m/m.
1.3. Maximum concentration of relevant impurities; in the case that they are not present, their absence must be indicated.
1.4. Minimum and maximum concentration of other additives present, expressed in g/kg, g/L, or percentage, when applicable and relevant to the specific case. The function must be indicated (for example, stabilizer).
1.5. The identity of the active ingredient, impurities, and additives (the latter when applicable and relevant to the specific case) must be indicated according to their IUPAC chemical name and the CAS number when available; if not available, the chemical structure must be presented.
1.6. If the active ingredient is a TK, the concentration on a dry basis must also be presented, and the maximum and minimum limits must be indicated.
2. Study of five lots conducted with the TGAI to be registered. Typically, the unidentified and unaccounted-for fraction of the technical grade active ingredient TC/TK must not exceed twenty grams per kilogram. The analyses and chromatograms (with their respective area) corresponding to each sampled lot must be attached and must comply with what is indicated in numeral 8.1.7 regarding the form of presentation of the study. In the event of not indicating the guideline or using a different one, it must comply with what is indicated in point 8.1.8. The results obtained in the five-lot study must comply with the limits established in the certificate of composition.
3. Justification for the determination of the manufacturing limits established for the technical grade active ingredient and impurities. The statistical basis or other technical criteria used to establish the manufacturing limits must be explained, and the respective technical justification of how they were obtained must be provided for evaluation by the SFE. If it is not a statistical criterion, supporting data must be provided to further justify the technical specification. Expert criteria must be technically justified.
4. Analysis of the identity of the technical grade active ingredient compared with the standard, which will consist of a set of analytical determinations that allow establishing the composition and constitution of the active ingredient unequivocally. For this purpose, two spectra of the active ingredient with their due interpretation must be presented, chosen from among the following: IR, NMR, Mass, and UV-VIS, with at least one between NMR or Mass being required. Both may also be presented if available. In case of doubt, the SFE, through a reasoned resolution, may request an additional test.
5. Identity of the impurities or eventually groups of related impurities present in the active ingredient synthesized by the manufacturer or under the manufacturer's supervision, which are listed in the certificate of composition; they must be identified by chemical and spectroscopic analyses with their due interpretation that allow concluding the identity of each impurity or group of related impurities beyond doubt and unequivocally.
6. Justification for the presence of impurities: the registrant must provide the necessary technical explanations for the presence of the impurities in the product. The justification must be based on chemical fundamentals. If the SFE determines that a relevant impurity may be present, it will request the technical justification as to why it has not been declared.
7. Analytical Methods and their respective validation used in the five-lot study, to determine impurities greater than or equal to one gram per kilogram (1 g/kg) or 0.1% m/m. Methods validated by CIPAC or other international organizations do not require analytical validation, unless they undergo alterations or modifications." 8. Summary of the manufacturing pathway. For each process resulting in a technical grade active ingredient, the following information must be provided:
8.1 Name and address of the manufacturer involved in the process.
8.2 General description of the process: description written in prose which must explain the steps necessary to carry out the synthesis of the product.
8.3 Manufacturing flow diagram.
8.4 Identification of the materials used to produce the product.
8.5 General description of the conditions controlled during the process, as the case may be: temperature, pressure, pH, and humidity.
- C)TECHNICAL DOSSIER CHEMICAL REQUIREMENTS 1. Structural formula (must include the stereochemistry of active isomers if applicable or known).
2. Analytical method and its respective validation for determining the purity of the technical grade active ingredient. The analytical method used in the five-lot analysis must be presented.
3. Analytical method and its respective validation for the determination of relevant impurities, including those that are below 0.1%.
TOXICOLOGICAL AND ENVIRONMENTAL REQUIREMENTS FOR THE TGAI 1. The toxicological, ecotoxicological, and environmental fate information for the TGAI extracted from the specification or report of EFSA, EPA, or FAO must be presented using the endpoint summary form in Annex Q; said data must match the most critical value reported in the reference sources.
2. The registrant may optionally submit the following information:
2.1. Acute oral median lethal dose (LD50), expressed in mg/kg of body weight (OECD Technical Guideline number 423). This study will be required in all cases unless the product is a gas or is highly volatile.
2.2. Acute dermal median lethal dose (LD50), expressed in mg/kg of body weight (OECD Technical Guideline number 402). This study will be required unless:
2.2.1. The product is a gas or is highly volatile.
2.2.2 The product is corrosive to the skin or has a pH less than 2 or greater than 11.5 2.3. Acute inhalation median lethal concentration (LC50), expressed in mg/l of air or mg/m3, for 4 hours of exposure (OECD Technical Guideline number 403). This will be requested when:
The product is a gas or liquefied gas, is a smoke-generating preparation or a fumigant, is used with fogging equipment, is a preparation that releases vapor, is an aerosol, is a powder containing a significant proportion of particles with a diameter less than 100 micrometers, is applied from an aircraft, contains active substances with a vapor pressure greater than 1 x 10-2 Pa and is to be used in enclosed spaces, or is to be applied in such a way that it generates particles or droplets with diameters less than 100 micrometers.
2.4. Dermal irritation (OECD Technical Guideline number 404). This study will be required unless:
2.4.1. The product is a gas or is highly volatile.
2.4.2 The product is corrosive to the skin or has a pH less than 2 or greater than 11.5.
2.5. Ocular irritation (OECD Technical Guideline number 405). This study will be required unless:
2.5.1 The product is a gas or is highly volatile.
2.5.2 The product is corrosive to the eyes or has a pH less than 2 or greater than 11.5.
2.6. Skin sensitization (OECD Technical Guideline number 406). This study will be required in all cases, except when: The product is known to be a skin sensitizer.
2.7. Dermal absorption of the active ingredient (Technical Guideline number 427 or 428). This study will be submitted when exposure through the skin constitutes an important route of exposure.
The interested party may justify, based on technical and/or scientific information, the non-submission of said study, with the Competent Reviewing Authority being responsible for reviewing whether it is accepted or not.
2.8. Study on Absorption, distribution, excretion, or metabolism in mammals (OECD Technical Guideline number 417).
2.8.1 This study must preferably be performed on rats.
2.8.2 Provide information on rates and extent of absorption and distribution in different tissues.
2.8.3 Provide information on the rate and extent of excretion, including relevant metabolites.
2.8.4 Identify metabolites and the metabolic pathway.
*In particular cases, the SFE may require additional studies in other species, such as hen or goat.
2.9. Subchronic toxicological studies.
2.9.1. Oral toxicity study, 90 days (OECD Technical Guideline number 408).
* In particular cases, the SFE may require any of the following studies if the results of the submitted studies are not considered conclusive by the CA. 2.9.1.1 90-day oral study (OECD Technical Guideline 409).
2.9.2 28-day oral study (OECD Technical Guideline 407).
2.9.3 28-day dermal study (OECD Technical Guideline 410).
2.9.4 90-day dermal study (OECD Technical Guideline 411).
2.9.5 28-day inhalation study (OECD Technical Guideline 412).
2.9.6 90-day inhalation study (OECD Technical Guideline 413).
2.10. Genotoxic studies (mutagenicity):
2.10.1. Bacterial reverse mutation test (OECD Technical Guideline 471).
2.10.2. Gene mutation test in mammalian cells (OECD Technical Guideline 476).
2.10.3. Micronucleus test (OECD Technical Guideline 474).
2.11. Chronic toxicological studies. Long-term toxicity and carcinogenesis must be determined.
2.11.1 24-month oral carcinogenicity study (OECD Technical Guideline 451).
2.11.2. Chronic toxicity study (OECD Technical Guideline 452).
2.11.3. Combined chronic toxicity/carcinogenicity study (OECD Technical Guideline 453).* * If a combined chronic toxicity/carcinogenicity study according to OECD Guideline 453 is submitted, it is not necessary to submit the studies indicated in subsections 11.1 and 11.2.
2.12. Reproduction studies.
2.12.1. Reproductive toxicity study, using the rat as the test animal and conducted over at least two generations (OECD Technical Guideline number 416).
* The SFE may require other studies, with prior technical and duly reasoned justification, this information being essential to proceed with the registration process. It may request complementary studies on: dominant lethal assay for male fertility; studies on cross-matings of dosed males with undosed females and vice versa; effects on spermatogenesis; effects on oogenesis; studies on sperm motility and morphology; study on hormonal activity.
2.13. Teratogenicity studies (OECD Technical Guideline number 414).
2.14. Neurotoxicity studies in compounds that have effects on the nervous system.
2.14.1. If the Technical Grade Active Ingredient is an organophosphate:
2.14.1.1. Acute neurotoxicity study (OECD Technical Guideline number 418).
2.14.1.2. 90-day subchronic delayed neurotoxicity study (OECD Technical Guideline number 419).
2.14.2. If the Technical Grade Active Ingredient is not an organophosphate:
Neurotoxicity study in rodents (OECD Technical Guideline number 424).
TOXICOLOGICAL REQUIREMENTS FOR NON-RELEVANT IMPURITIES:
Information must be submitted demonstrating that the non-relevant impurities greater than 1 g/kg present in the product do not have toxicological relevance. For this purpose, structure-activity studies or toxicological contribution analysis of the impurities may be provided. The procedure established in Annex H of the Manual on Development and Use of FAO and WHO Specifications for chemical pesticides, 2022 edition, or its most recent version, may also be used.
ECOTOXICOLOGICAL REQUIREMENTS FOR NON-RELEVANT IMPURITIES:
1. Information must be submitted demonstrating that the non-relevant impurities greater than 1 g/kg present in the product do not have ecotoxicological relevance for the organisms indicated below. For this purpose, laboratory studies with the recommended guidelines, or structure-activity studies or ecotoxicological contribution analysis of the impurities may be provided. The procedure established in Annex H of the Manual on Development and Use of FAO and WHO Specifications for chemical pesticides, 2022 edition, or its most recent version, may also be used.
1.1. Acute oral toxicity in birds. The use of guideline OCSPP 850.2100 is recommended.
1.2. Acute oral toxicity for bees. The use of guideline OECD 213 is recommended.
1.3 Acute contact toxicity for bees. The use of guideline OECD 214, OCSPP 850.3020 is recommended.
1.4 Acute toxicity in fish. The use of guideline OECD 203, OCSPP 850.1075 is recommended.
1.5 Acute toxicity in Daphnia sp. The use of guideline OECD 202 or OCSPP 850.1010 is recommended.
1.6 Effect on the growth of algae or aquatic plants. The use of guideline OECD 201, OCSPP 850.5400 is recommended."
(Normative) Endpoint summary form for the toxicological, ecotoxicological, and environmental fate information supporting the TGAI registration with reference information from an Internationally Recognized Authority.
The following tables must be completed according to the most critical toxicological, ecotoxicological, and environmental fate data indicated in the specification, report, or dossier of the reference information, and must be completed according to the corresponding instructions for each table.
Table 1. Summary of the general product data extracted from the specification or report of the information source.
| PRODUCT DESCRIPTION AND LABELING | | | | --- | --- | --- | | TRADE NAME: | CAS NUMBER: | MINIMUM A.I. CONTENT: | | SYNONYMS: | MOLECULAR MASS: | | | PESTICIDE TYPE: | CHEMICAL GROUP: | | | REGISTRANT: | | | | MANUFACTURER: | COUNTRY OF ORIGIN: | | | TOXICOLOGICAL CLASSIFICATION: | | | | LABEL: | All data and pictograms related to the environment, human health and safety, as well as the corresponding band color, match the information from the reference sources used for the product to be registered. | | | SAFETY DATA SHEET: | All data and pictograms match the approved references for the product to be registered regarding the environment, human health and safety. All data and pictograms related to the environment, human health and safety, as well as the corresponding band color, match the information from the reference sources used for the product to be registered. | | Table 2. Summary of the toxicological data extracted from the specification, report, or dossier of the reference source.
| Toxicological Data | Required Study/Unit1 | Toxicity Data or Endpoint2. | Page in the specification, report, or evaluation dossier of the reference source | | --- | --- | --- | --- | | Acute toxicity | Acute oral median lethal dose (mg/kg body weight) | Species or strain: | | | LD50: | | | | | Acute dermal median lethal dose (mg/kg body weight) | Species or strain: | | | | LD50: | | | | | Acute inhalation median lethal concentration (mg/L air) | Species or strain: | | | | LC50: | | | | | Dermal irritation | Species or strain: | | | | 3Degree of irritation: | | | | | Ocular irritation | Species or strain: | | | | 3Degree of irritation: | | | | | Skin sensitization | Species or strain: | | | | 3Degree of sensitization: | | | | | Dermal absorption | Dermal absorption of the active ingredient | Species or strain: | | | 4Absorption rate: | | | | | Metabolism | Absorption, distribution, excretion, or metabolism in mammals | Species or strain: | | | 4Rate and extent of absorption: | | | | | Distribution: | | | | | 4Rate and extent of excretion: | | | | | Relevant metabolites: | | | | | Metabolic pathway: | | | | | Subchronic toxicity | Oral toxicity, 90 days | Species or strain: | | | Target organ/critical effect: | | | | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | Mutagenicity | Bacterial reverse mutation test | Species or strain: | | | Presence or absence of genotoxic effects: | | | | | Gene mutation test in mammalian cells | Species or strain: | | | | Presence or absence of genotoxic effects: | | | | | Micronucleus test | Species or strain: | | | | Presence or absence of genotoxic effects: | | | | | Chronic toxicity | 24-month oral carcinogenicity | Species or strain: | | | Target organ/critical effect: | | | | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | Chronic toxicity | Species or strain: | | | | Target organ/critical effect: | | | | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | | Combined chronic toxicity/carcinogenicity | Target organ/critical effect: | | | | --- | --- | --- | --- | --- | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | | Reproductive toxicity | Reproductive toxicity conducted over two generations | Species or strain: | | | | Target organ/critical effect: | | | | | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | | Developmental toxicity | Teratogenicity studies | Species or strain: | | | | Target organ/critical effect: | | | | | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | | Neurotoxicity | If the Technical Grade Active Ingredient is an organophosphate | Acute neurotoxicity | Species or strain: | | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | | 90-day subchronic delayed neurotoxicity | Species or strain: | | | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | | If the Technical Grade Active Ingredient is not an organophosphate | Neurotoxicity in rodents | Species or strain: | | | | 5NOAEL, LOAEL, NOEL, LOEL: | | | | | | Other toxicological studies | For this section, additional information may be provided if it was required by the Regulatory Authority. | According to the requested studies. | | | 1. Verify that the data are indicated according to the recommended unit.
2. Note the most critical value (the lowest concentration causing a toxic effect) available in the reference sources.
3. Refers to the irritation or sensitization category.
4. Place the specific percentage data.
5. Unit: mg/kg body weight per day.
Table 3. Summary of ecotoxicological data extracted from the specification or report of the reference source.
| Ecotoxicological Data | Required Study and Unit | Toxicity Data or Endpoint (1value, 2species, and 3time) | Page in the specification, report, or evaluation dossier of the reference source | | --- | --- | --- | --- | | Effects on terrestrial organisms | Acute oral toxicity in birds (mgAI/kg body weight) | 4 LD50: Species: Time: | | | Effects on bird reproduction (mgAI/kg diet or mg/kg body weight) | 4 NOEC: | | | | Acute oral toxicity for bees (µgAI/bee) | 4 LD50: | | | | Acute contact toxicity for bees (µgAI/bee) | 4 LD50: | | | | Toxicity for earthworms (mgAI/kg dry soil) | 4 EC50 / NOEC: | | | | | Acute toxicity for fish (mgAI/L) | 4 LC50: | | | Effects on aquatic organisms | 5Prolonged toxicity for fish (mgAI/L) The available value must be reported. | Early-life stage toxicity in fish 4 NOEC: | | | | | Fish full life cycle study. 4 NOEC: | | | | Bioaccumulation in fish (mL/g whole fish) | 6 BCF: | | | | Acute toxicity in Daphnia sp. (mgAI/L) | 4 EC50: | | | | Chronic toxicity in Daphnia sp. (mgAI/L) | 4 NOEC: | | | | Toxicity in algae (mgAI/L) | 4 ErC50: 4 EbC50: | | 1. Verify that the data are indicated according to the recommended unit.
2. Indicate the species corresponding to the indicated value.
3. Indicate the time of the data or endpoint used, when available.
4. Record the most critical value (the lowest concentration causing a toxic effect) available in the reference source.
5. Record the value when applicable according to Costa Rican legislation.
6. Record the most critical value (the highest BCF) available in the reference source and when applicable according to Costa Rican legislation.
Table 4. Summary of environmental fate and behavior data extracted from the reference source | Environmental compartment | Required study and unit | Environmental fate data or endpoint (1value) | Folio in the specification, report, or assessment report of the reference source | | --- | --- | --- | --- | | Soil | Aerobic degradation in soil (days) | 2 DT50: | | | Environmental compartment | Required study and unit | Environmental fate data or endpoint (1value) | Folio in the specification, report, or assessment report of the reference source | | --- | --- | --- | --- | | | Adsorption and desorption (mL/g) | 3 Kfoc /Koc (Adsorption): | | | 4 Leaching in soil (required when the adsorption/desorption study presents a Koc < 15 mL/g) | "% substance in the column: % substance in the leachate:" | | | | Water | Aerobic degradation in water (days) | 2 DT50 (water): 2 DT50 (sediment)5: 2 DT50 (system): | | | Hydrolysis (days) | 2 DT50: | | | | Aqueous photolysis (days) | 2 DT50 (with light): 2 DT50 (without light): | | | | n-Octanol/water partition coefficient (KO/W). | Log PO/W: | | | | Water solubility (mg/L) at pH 7 | | | | | Air | Vapor pressure (Pa) | | | | Density (mg/L) | | | | | 6 RELEVANT METABOLITES | | | | | Identification, name or code | 7 Percentage of occurrence | Folio in the specification or assessment report of the reference source | | 1.
1. Verify that the data are indicated according to the recommended unit.
2. Record the most critical value (the highest value) available in the reference source.
3. Record the minimum and maximum values available in the reference source.
4. When applicable according to Costa Rican legislation.
5. Record the data when it is available in the reference source.
6. Must list the relevant metabolites indicated in the reference source when they are available.
7. Indicate the maximum percentage at which it was measured in soil, water, and/or sediment."